- Home
- RYN vs AMRX Comparison
RYN vs AMRX Comparison
Compare RYN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYN
- AMRX
- Stock Information
- Founded
- RYN 1926
- AMRX 2002
- Country
- RYN United States
- AMRX United States
- Employees
- RYN N/A
- AMRX 8100
- Industry
- RYN Real Estate Investment Trusts
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- RYN Real Estate
- AMRX Health Care
- Exchange
- RYN Nasdaq
- AMRX Nasdaq
- Market Cap
- RYN 4.0B
- AMRX 3.3B
- IPO Year
- RYN N/A
- AMRX N/A
- Fundamental
- Price
- RYN $26.25
- AMRX $10.38
- Analyst Decision
- RYN Hold
- AMRX Strong Buy
- Analyst Count
- RYN 4
- AMRX 4
- Target Price
- RYN $28.00
- AMRX $12.00
- AVG Volume (30 Days)
- RYN 1.1M
- AMRX 1.8M
- Earning Date
- RYN 11-05-2025
- AMRX 10-30-2025
- Dividend Yield
- RYN 10.98%
- AMRX N/A
- EPS Growth
- RYN 389.17
- AMRX N/A
- EPS
- RYN 4.92
- AMRX 0.01
- Revenue
- RYN $1,239,943,000.00
- AMRX $2,852,914,000.00
- Revenue This Year
- RYN N/A
- AMRX $9.56
- Revenue Next Year
- RYN $4.07
- AMRX $6.27
- P/E Ratio
- RYN $5.35
- AMRX $954.93
- Revenue Growth
- RYN 40.53
- AMRX 9.81
- 52 Week Low
- RYN $21.84
- AMRX $6.69
- 52 Week High
- RYN $32.88
- AMRX $10.68
- Technical
- Relative Strength Index (RSI)
- RYN 51.55
- AMRX 65.50
- Support Level
- RYN $25.76
- AMRX $10.35
- Resistance Level
- RYN $27.06
- AMRX $10.67
- Average True Range (ATR)
- RYN 0.45
- AMRX 0.26
- MACD
- RYN 0.01
- AMRX 0.04
- Stochastic Oscillator
- RYN 54.72
- AMRX 76.69
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.